110 related articles for article (PubMed ID: 26753478)
1. Serum prolactin concentration and severity of depression symptoms in climacteric women.
Słopień R; Słopień A; Warenik-Szymankiewicz A
Clin Exp Obstet Gynecol; 2015; 42(6):749-51. PubMed ID: 26753478
[TBL] [Abstract][Full Text] [Related]
2. Depressive symptoms and hormonal profile in climacteric women.
Słopień R; Słopień A; Warenik-Szymankiewicz A; Sajdak S
Clin Exp Obstet Gynecol; 2015; 42(3):285-91. PubMed ID: 26151994
[TBL] [Abstract][Full Text] [Related]
3. Disturbances of sleep continuity in women during the menopausal transition.
Słopień R; Wichniak A; Pawlak M; Słopień A; Warenik-Szymankiewicz A; Sajdak S
Psychiatr Pol; 2015; 49(3):615-23. PubMed ID: 26276926
[TBL] [Abstract][Full Text] [Related]
4. The genetic background of climacteric symptoms in women during menopause.
Slopień R; Rózycka A; Slopień A; Pawlak M; Warenik-Szymankiewicz A; Sajdak S; Jagodziński P
Clin Exp Obstet Gynecol; 2016; 43(4):495-499. PubMed ID: 29734534
[TBL] [Abstract][Full Text] [Related]
5. Correlation between allopregnanolone levels and depressive symptoms during late menopausal transition and early postmenopause.
Slopien R; Pluchino N; Warenik-Szymankiewicz A; Sajdak S; Luisi M; Drakopoulos P; Genazzani AR
Gynecol Endocrinol; 2018 Feb; 34(2):144-147. PubMed ID: 28857628
[TBL] [Abstract][Full Text] [Related]
6. Depression in premenopausal women: gonadal hormones and serotonergic system assessed by D-fenfluramine challenge test.
Rajewska J; Rybakowski JK
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun; 27(4):705-9. PubMed ID: 12787860
[TBL] [Abstract][Full Text] [Related]
7. Depressive symptoms' pattern in postmenopausal women.
Slopień R; Slopień A; Pawlak M; Warenik-Szymankiewicz A; Sajdak S
Clin Exp Obstet Gynecol; 2016; 43(4):544-545. PubMed ID: 29734545
[TBL] [Abstract][Full Text] [Related]
8. [Serum hormone level and Kupperman menopausal complaints in sexually mature women with disturbance of ovulation].
Kano T; Nishikawa K
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jan; 37(1):31-7. PubMed ID: 3919122
[TBL] [Abstract][Full Text] [Related]
9. Effects of ECT on prolactin, LH, FSH and testosterone in males with major depressive illness.
Cooper AJ; Finlayson R; Velamoor VR; Magnus RV; Cernovsky Z
Can J Psychiatry; 1989 Nov; 34(8):814-7. PubMed ID: 2510920
[TBL] [Abstract][Full Text] [Related]
10. Relationship between climacteric symptoms and serum serotonin levels in postmenopausal women.
Słopień R; Meczekalski B; Warenik-Szymankiewicz A
Climacteric; 2003 Mar; 6(1):53-7. PubMed ID: 12725665
[TBL] [Abstract][Full Text] [Related]
11. Relationship between climacteric symptoms and serum galanin levels in post-menopausal women.
Słopien R; Meczekalski B; Warenik-Szymankiewicz A
J Endocrinol Invest; 2004 Oct; 27(9):RC21-3. PubMed ID: 15648541
[TBL] [Abstract][Full Text] [Related]
12. Climacteric symptoms are related to thyroid status in euthyroid menopausal women.
Slopien R; Owecki M; Slopien A; Bala G; Meczekalski B
J Endocrinol Invest; 2020 Jan; 43(1):75-80. PubMed ID: 31392574
[TBL] [Abstract][Full Text] [Related]
13. Climacteric symptoms, fat mass, and plasma concentrations of LH, FSH, Prl, oestradiol-17 beta and androstenedione in the early post-menopausal period.
Hagen C; Christiansen C; Christensen MS; Transbøl I
Acta Endocrinol (Copenh); 1982 Sep; 101(1):87-92. PubMed ID: 6812347
[No Abstract] [Full Text] [Related]
14. [Relationship between climacteric symptoms and serum neuropeptide Y level in postmenopausal women].
Słopień R; Meczekalski B; Warenik-Szymankiewicz A
Ginekol Pol; 2003 Sep; 74(9):1023-8. PubMed ID: 14674163
[TBL] [Abstract][Full Text] [Related]
15. Correlation between climacteric symptoms and serum levels of estradiol, progesterone, follicle-stimulating hormone, and luteinizing hormone.
Abe T; Furuhashi N; Yamaya Y; Wada Y; Hoshiai A; Suzuki M
Am J Obstet Gynecol; 1977 Sep; 129(1):65-7. PubMed ID: 900171
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial.
Soares CN; Almeida OP; Joffe H; Cohen LS
Arch Gen Psychiatry; 2001 Jun; 58(6):529-34. PubMed ID: 11386980
[TBL] [Abstract][Full Text] [Related]
17. Do estradiol levels influence on the cognitive function during antidepressant treatments in post-menopausal women with major depressive disorder? A comparison with pre-menopausal women.
Pae CU; Mandelli L; Han C; Ham BJ; Masand PS; Patkar AA; Steffens DC; De Ronchi D; Serretti A
Neuro Endocrinol Lett; 2008 Aug; 29(4):500-6. PubMed ID: 18766158
[TBL] [Abstract][Full Text] [Related]
18. Studies with clonidine (dixarit) in menopausal women.
Schindler AE; Müller D; Keller E; Göser R; Runkel F
Arch Gynecol; 1979; 227(4):341-7. PubMed ID: 518136
[TBL] [Abstract][Full Text] [Related]
19. Age, insulin, SHBG and sex steroids exert secondary influence on plasma leptin level in women.
Milewicz T; Krzysiek J; Janczak-Saif A; Sztefko K; Krzyczkowska-Sendrakowska M
Endokrynol Pol; 2005; 56(6):883-90. PubMed ID: 16821206
[TBL] [Abstract][Full Text] [Related]
20. The 5HTT and MAO-A polymorphisms associate with depressive mood and climacteric symptoms in postmenopausal women.
Grochans E; Grzywacz A; Jurczak A; Samochowiec A; Karakiewicz B; Brodowska A; Starczewski A; Samochowiec J
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():125-30. PubMed ID: 23707423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
